Identification of Mepenzolate Derivatives With Long-Acting Bronchodilatory Activity
The standard treatment for chronic obstructive pulmonary disease is a combination of anti-inflammatory drugs and bronchodilators. We recently found that mepenzolate bromide (MP), an antagonist for human muscarinic M3 receptor (hM3R), has both anti-inflammatory and short-acting bronchodilatory activi...
| Үндсэн зохиолчид: | , , , , , , , , , |
|---|---|
| Формат: | Өгүүллэг |
| Хэл сонгох: | English |
| Хэвлэсэн: |
Frontiers Media S.A.
2018-04-01
|
| Цуврал: | Frontiers in Pharmacology |
| Нөхцлүүд: | |
| Онлайн хандалт: | http://journal.frontiersin.org/article/10.3389/fphar.2018.00344/full |